Crispr Therapeutics (CRSP) is up 11.9%, or $6.57 to $61.66.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRSP:
- Crispr Therapeutics AG Stock Soars Amid Strategic Moves
- Cathie Wood Makes $5M Biotech Buy, Trims Stake in Roku
- Cathie Wood’s ARK Investment buys 103K shares of Crispr Therapeutics today
- Crispr Therapeutics AG: Strategic Positioning and Growth Potential in Gene Editing
- Largest borrow rate increases among liquid names